Skip to content
healthcare.dev
Get a free key

FLUARIX 2026/2027

NDC 58160-725, influenza virus vaccine, suspension, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-725
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125127
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-725 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
  • INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
Package NDCNDC-11Package
58160-725-525816007255210 SYRINGE in 1 CARTON (58160-725-52) / .5 mL in 1 SYRINGE (58160-725-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58160-725 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-725 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-725. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.